Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors

Trial Profile

Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jun 2017

At a glance

  • Drugs Dendritic cells (Primary) ; Poly ICLC (Primary)
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Apr 2017 Status changed from recruiting to completed.
    • 02 Dec 2015 Number of treatment arms changed from 1 to 2, A new cohort will explore the role of radiation therapy, looking for an abscopal effect as reported by ClinicalTrials.gov.
    • 26 Jan 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top